// App-Quantinova.ai

1020 : Comparison of tissue genotyping (TG) vs circulating tumor DNA (ctDNA) for selection of matched therapy and impact on clinical outcomes among patients with metastatic breast cancer (MBC).

Researchers

Presenter

  • Neelima Vidula

Principal Investigators

  • Dejan Juric

  • Andrzej Niemierko

  • Laura Spring

  • Beverly Moy

  • Giuliana Malvarosa

  • Megan Yuen

  • Karleen R. Habin

  • Jennifer Adrienne Shin

  • Jeffrey M. Peppercorn

  • Steven J. Isakoff

  • Leif W. Ellisen

  • A. John Iafrate

  • Aditya Bardia

Medical Centers

  • UC San Francisco, San Francisco, CA

  • Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA

  • Massachusetts General Hospital Cancer Center, Boston, MA

  • Brigham and Women's Hospital, Brookline, MA

  • Massachusetts General Hospital, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Circulating DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved